157 related articles for article (PubMed ID: 29633930)
1. Clinical Significance of Pulmonary Nodules in the Pretransplant Evaluation of Liver Transplant Recipients With Hepatocellular Carcinoma.
Serrano OK; Olgun DC; Goduguchinta V; Bangdiwala A; Odegard MN; Kandaswamy R; Matas AJ; Lake JR; Pruett TL; Chinnakotla S
Exp Clin Transplant; 2018 Jun; 16(3):314-320. PubMed ID: 29633930
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary nodules in liver transplant candidates with hepatocellular carcinoma: Imaging characteristics and clinical outcomes.
Lee C; Ihde L; Kim A; Santos I; Matsuoka L; Cen Y; Wallman M; Grant E
Liver Transpl; 2015 Sep; 21(9):1169-78. PubMed ID: 25845578
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
[TBL] [Abstract][Full Text] [Related]
4. Tumor Characteristics and Long-Term Outcome of Incidental Hepatocellular Carcinoma After Orthotopic Liver Transplant.
Mourad MM; Algarni A; Aly MA; Gunson BK; Mergental H; Isaac J; Muiesan P; Mirza D; Perera MT; Bramhall SR
Exp Clin Transplant; 2015 Aug; 13(4):333-8. PubMed ID: 26295183
[TBL] [Abstract][Full Text] [Related]
5. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
[TBL] [Abstract][Full Text] [Related]
6. Revisiting the role of pathological analysis in transarterial chemoembolization-treated hepatocellular carcinoma after transplantation.
Vasuri F; Malvi D; Rosini F; Baldin P; Fiorentino M; Paccapelo A; Ercolani G; Pinna AD; Golfieri R; Morselli-Labate AM; Grigioni WF; D'Errico-Grigioni A
World J Gastroenterol; 2014 Oct; 20(37):13538-45. PubMed ID: 25309084
[TBL] [Abstract][Full Text] [Related]
7. Patterns of Discordance Between Pretransplant Imaging Stage of Hepatocellular Carcinoma and Posttransplant Pathologic Stage: A Contemporary Appraisal of the Milan Criteria.
Ecker BL; Hoteit MA; Forde KA; Hsu CC; Reddy KR; Furth EE; Siegelman ES; Habibollahi P; Ben-Josef E; Porrett PM; Abt PL; Shaked A; Olthoff KM; Levine MH
Transplantation; 2018 Apr; 102(4):648-655. PubMed ID: 29319629
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary nodules at risk in patients undergoing liver transplantation for hepatocellular carcinoma.
Sotiropoulos GC; Kuehl H; Sgourakis G; Molmenti EP; Beckebaum S; Cicinnati VR; Baba HA; Schmitz KJ; Broelsch CE; Lang H
Transpl Int; 2008 Sep; 21(9):850-6. PubMed ID: 18466170
[TBL] [Abstract][Full Text] [Related]
9. Predicting survival after liver transplantation using up-to-seven criteria in patients with hepatocellular carcinoma.
de Ataide EC; Garcia M; Mattosinho TJ; Almeida JR; Escanhoela CA; Boin IF
Transplant Proc; 2012 Oct; 44(8):2438-40. PubMed ID: 23026614
[TBL] [Abstract][Full Text] [Related]
10. Pilot study of living donor liver transplantation for patients with hepatocellular carcinoma exceeding Milan Criteria (Barcelona Clinic Liver Cancer extended criteria).
Llovet JM; Pavel M; Rimola J; Diaz MA; Colmenero J; Saavedra-Perez D; Fondevila C; Ayuso C; Fuster J; Ginès P; Bruix J; Garcia-Valdecasas JC
Liver Transpl; 2018 Mar; 24(3):369-379. PubMed ID: 29140601
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
Sasaki K; Firl DJ; Hashimoto K; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Fung JJ; Aucejo FN; Miller CM
Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):595-603. PubMed ID: 28546007
[TBL] [Abstract][Full Text] [Related]
12. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
[TBL] [Abstract][Full Text] [Related]
13. Outcome of Living-Donor Liver Transplant for Hepatocellular Carcinoma: 15-Year Single-Center Experience in Egypt.
Kamel R; Hatata Y; Hosny K; Nabil A; El-Deen Abd-Allah A; Mostafa A; Abdel-Aal A; Elganzoury MZ; Elmalt O; Marwan I; Hosny A
Exp Clin Transplant; 2017 Mar; 15(Suppl 2):12-20. PubMed ID: 28301993
[TBL] [Abstract][Full Text] [Related]
14. Living donor liver transplantation for hepatocellular carcinoma.
Isik B; Ince V; Karabulut K; Kayaalp C; Yilmaz S
Transplant Proc; 2012; 44(6):1713-6. PubMed ID: 22841251
[TBL] [Abstract][Full Text] [Related]
15. Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on "number of patients needed to transplant" as measure of transplant benefit.
Vitale A; Cucchetti A; Qiao GL; Cescon M; Li J; Ramirez Morales R; Frigo AC; Xia Y; Tuci F; Shen F; Cillo U; Pinna AD
J Hepatol; 2014 Jun; 60(6):1165-71. PubMed ID: 24508550
[TBL] [Abstract][Full Text] [Related]
16. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
[TBL] [Abstract][Full Text] [Related]
17. Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.
Schwartz JJ; Pappas L; Thiesset HF; Vargas G; Sorensen JB; Kim RD; Hutson WR; Boucher K; Box T
Liver Transpl; 2012 Apr; 18(4):423-33. PubMed ID: 22250078
[TBL] [Abstract][Full Text] [Related]
18. Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: retrospective analysis.
Li HL; Ji WB; Zhao R; Duan WD; Chen YW; Wang XQ; Yu Q; Luo Y; Dong JH
World J Gastroenterol; 2015 Mar; 21(12):3599-606. PubMed ID: 25834326
[TBL] [Abstract][Full Text] [Related]
19. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
Hanouneh IA; Macaron C; Lopez R; Aucejo F; Zein NN
Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852
[TBL] [Abstract][Full Text] [Related]
20. Clinical Significance of Multiple Pulmonary Metastasectomy for Hepatocellular Carcinoma.
Mizuguchi S; Nishiyama N; Izumi N; Tsukioka T; Komatsu H; Iwata T; Tanaka S; Takemura S; Kubo S
World J Surg; 2016 Feb; 40(2):380-7. PubMed ID: 26306890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
